TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30928924

Group type: EXPERIMENTAL
Intervention: Combined lumbar and sacral plexus block plus sedation
Number of subjects: 1086

Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 1086
Study: 29406521

Group type: EXPERIMENTAL
Intervention: Increasing number of low-energy-dense (LED) foods consumed
Number of subjects: 183

Group type: COMPARATOR
Intervention: Decreasing number of high-energy-dense (HED) foods consumed
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Participants consuming ≤2 HED foods per day and ≥6.6 LED foods per day
Number of subjects: 183
Study: 27368915

Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiotherapy (IMRT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Three-Dimensional Conformal Radiotherapy (3D CRT)
Number of subjects: 40
Study: 24916319

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy with support to taper/discontinue antidepressant medication (MBCT-TS)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Maintenance antidepressant treatment (m-ADM)
Number of subjects: 420
Study: 22249280

Group type: EXPERIMENTAL
Intervention: Two to four arms into the obturator foramen (TO)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Fixed to the arcus tendineous fascia pelvis (FG)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Two arms into the retropubic space (RP)
Number of subjects: 230
Study: 22455270

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 50

Group type: COMPARATOR
Intervention: PGF2alpha
Number of subjects: 50
Study: 16675509

Group type: EXPERIMENTAL
Intervention: Ondansetron infusion at 250 ng/ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 15324521

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg plus ezetimibe 10 mg (n = 12)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg plus placebo (n = 12)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg plus placebo (n = 8)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (n = 8)
Number of subjects: 40
Study: 11275915

Group type: EXPERIMENTAL
Intervention: Medical therapy guided by a combination of clinical assessment and hemodynamic monitoring (PAC arm)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Medical therapy guided by clinical assessment alone (CLIN arm)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: PAC arm
Number of subjects: 500
Study: 9284842

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (e.g., nifedipine, diltiazem, verapamil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long acting formulations and newer calcium channel blockers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other drug classes
Number of subjects: 0
Study: 8330066

Group type: EXPERIMENTAL
Intervention: Active Specific Immunotherapy (A.S.I.) with autologous irradiated tumor cells mixed with BCG (10^7) injected intradermally on days 28 and 35 after surgery.
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Active Specific Immunotherapy (A.S.I.) with autologous irradiated tumor cells alone injected intradermally on day 42 after surgery.
Number of subjects: 113

Group type: COMPARATOR
Intervention: Observation (Control group).
Number of subjects: 113
Study: 3791362

Group type: EXPERIMENTAL
Intervention: Somophyllin‐CRT (500 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Theo‐Dur (600 mg)
Number of subjects: 8
Study: 31883730

Group type: EXPERIMENTAL
Intervention: Self-reported hand hygiene after toileting
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Self-reported hand hygiene before eating
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Desire for more information about hand hygiene
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Key themes from interviews
Number of subjects: 268
Study: 30293833

Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Pectoral Nerves II Block (Pecs II)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Intercostal Nerve Block (ICNB)
Number of subjects: 108
Study: 27752827

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT/MED) using R&R2ADHD programme
Number of subjects: 95

Group type: COMPARATOR
Intervention: Treatment as usual (TAU/MED)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT/MED)
Number of subjects: 95
Study: 25874243

Group type: EXPERIMENTAL
Intervention: NSAID (sodium diclofenac)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Panacea (sodium diclofenac + carisoprodol + acetaminophen + caffeine)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24119858

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 110
Study: 22085440

Group type: EXPERIMENTAL
Intervention: Healthy Homework programme
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study: 19543121

Group type: EXPERIMENTAL
Intervention: Higher quartiles of conscientiousness
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 370
Study: 17192499

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Roflumilast 250 microg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Roflumilast 250 microg and 500 microg
Number of subjects: 15
Study: 16392539

Group type: EXPERIMENTAL
Intervention: random whole-body vibration (rWBV)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 12126092

Group type: EXPERIMENTAL
Intervention: 99mTc-sestamibi
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (normal controls, NC)
Number of subjects: 25
Study: 11208239

Group type: EXPERIMENTAL
Intervention: Combination diet (fruits, vegetables, low-fat dairy, low total and saturated fat)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Fruits-and-vegetables diet
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 459
Study: 7826297

Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine tartrate
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.5% timolol maleate
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.25% betaxolol suspension
Number of subjects: 24

Group type: COMPARATOR
Intervention: brimonidine vehicle
Number of subjects: 24
Study: 2351301

Group type: EXPERIMENTAL
Intervention: Intragastric infusion of 160 ml autologous venous blood
Number of subjects: 6

Group type: COMPARATOR
Intervention: Intragastric infusion of 160 ml egg white (Control)
Number of subjects: 6
Study: 489262

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 31248745

Group type: EXPERIMENTAL
Intervention: Higher-Frequency Feedback
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Lower-Frequency Feedback
Number of subjects: 1125
Study: 29051044

Group type: EXPERIMENTAL
Intervention: Glucose control therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ordinary least squares (OLS) regression models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analyses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random assignment to treatment
Number of subjects: 0
Study: 26060821

Group type: EXPERIMENTAL
Intervention: Rebamipide
Number of subjects: 206

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 206
Study: 23808433

Group type: EXPERIMENTAL
Intervention: FOS enriched cookie
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control cookie
Number of subjects: 38
Study: 21605236

Group type: EXPERIMENTAL
Intervention: Monophasic hyaluronic acid (mono-HA) filler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biphasic hyaluronic acid (bi-HA) filler
Number of subjects: 0
Study: 19372172

Group type: EXPERIMENTAL
Intervention: Forced-use group (standard rehabilitation + restraining sling on nonparetic arm for 6 hours per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard training group (standard rehabilitation only)
Number of subjects: 30
Study: 17115981

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 15337017

Group type: EXPERIMENTAL
Intervention: Cardiac support device (CSD)
Number of subjects: 10
Study: 11343523

Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 9552776

Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block (SPGB) with 4% lidocaine
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Trigger point injections (TPI) with 1% lidocaine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sphenopalatine ganglion block (SPGB) with saline placebo
Number of subjects: 23
Study: 7812583

Group type: EXPERIMENTAL
Intervention: Dressing foot wrap
Number of subjects: 25

Group type: COMPARATOR
Intervention: Laminated foam boot (Lunax, BIO-SONICS)
Number of subjects: 25
Study: 2685471

Group type: EXPERIMENTAL
Intervention: 3 gms L-tryptophan
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76

Group type: COMPARATOR
Intervention: No substances
Number of subjects: 76
Study: 970882

Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and antrectomy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 22
Study: 31064973

Group type: EXPERIMENTAL
Intervention: Fringed fall prevention program (6 sessions, 60 minutes group sessions, 20-30 minutes individual sessions)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 97
Study: 28775061

Group type: EXPERIMENTAL
Intervention: High-Density Lipoprotein Cholesterol (HDL-C)
Number of subjects: 17661

Group type: EXPERIMENTAL
Intervention: Apolipoprotein A-I (apoA-I)
Number of subjects: 17661
Study: 25532068

Group type: EXPERIMENTAL
Intervention: Pyridoxamine dihydrochloride (Pyridorin™)
Number of subjects: 0
Study: 22141358

Group type: EXPERIMENTAL
Intervention: Corticocancellous porcine bone grafting after extraction
Number of subjects: 40

Group type: COMPARATOR
Intervention: No grafting after extraction
Number of subjects: 40
Study: 20889142

Group type: EXPERIMENTAL
Intervention: Sleep Deprived Group
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sleep Control Group
Number of subjects: 28
Study: 18561587

Group type: EXPERIMENTAL
Intervention: HESA-A tablet 25 mg/kg twice a day orally
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 15662490

Group type: EXPERIMENTAL
Intervention: Duloxetine (40 mg BID)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Duloxetine (study completers)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo (study completers)
Number of subjects: 451
Study: 12455078

Group type: EXPERIMENTAL
Intervention: AMI patients (postprocedural FFR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: AMI patients with TIMI 2
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (stable angina pectoris)
Number of subjects: 48
Study: 10631421

Group type: EXPERIMENTAL
Intervention: Pigtail CVC
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard CVC
Number of subjects: 203
Study: 7793450

Group type: EXPERIMENTAL
Intervention: Inositol 12 g/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 1823741

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7048671

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC) administration during daytime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine diagnostic tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preliminary screening method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evaluating parasitological response
Number of subjects: 0
Study: 31318796

Group type: EXPERIMENTAL
Intervention: Uncorrected refractive error
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Presbyopia
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Spectacle coverage for distance vision
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Spectacle coverage for presbyopia
Number of subjects: 2886

Group type: EXPERIMENTAL
Intervention: Barriers to spectacle uptake
Number of subjects: 2886
Study: 29199186

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 25516991

Group type: EXPERIMENTAL
Intervention: Ice application for 3 minutes before arterial puncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ice application)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ice application in naive group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group in naive group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ice application in experienced group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group in experienced group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ice application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 23791399

Group type: EXPERIMENTAL
Intervention: EnSeal device
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard bipolar coagulation forceps
Number of subjects: 160
Study: 22419265

Group type: EXPERIMENTAL
Intervention: Fixed weight-bearing device
Number of subjects: 300

Group type: COMPARATOR
Intervention: Mobile weight-bearing device
Number of subjects: 300
Study: 19542476

Group type: EXPERIMENTAL
Intervention: 4-month treatment arm
Number of subjects: 370

Group type: COMPARATOR
Intervention: 6-month treatment arm
Number of subjects: 370
Study: 17697456

Group type: EXPERIMENTAL
Intervention: Prednisolone acetate 1% formulation A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisolone acetate 1% formulation B
Number of subjects: 0
Study: 16829672

Group type: EXPERIMENTAL
Intervention: Rocuronium (R)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline (S)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall recordings
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Loss of eyelash reflex (LER)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Steady state (SS) for all patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Steady state (SS) for Group S
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Steady state (SS) for Group R
Number of subjects: 25
Study: 14632962

Group type: EXPERIMENTAL
Intervention: Nortriptyline 150 mg/day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fluoxetine 60 mg/day
Number of subjects: 48
Study: 10928310

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (4, 8, 16 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (1/0.25, 2/0.5, 4/1, 8/2, 16/4 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Intramuscular hydromorphone (2, 4 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 8872617

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid therapy (2 x 100 micrograms beclomethasone 4 times/day for 2.5 yr)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No inhaled glucocorticoid therapy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Asthmatic smokers
Number of subjects: 15

Group type: COMPARATOR
Intervention: Asthmatic nonsmokers
Number of subjects: 15
Study: 1531234

Group type: EXPERIMENTAL
Intervention: 10‐0 nylon suture
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 10‐0 polypropylene (Prolene) suture
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 11‐0 polyester (Mersilene) suture
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 10‐0 polyethylene (Novafil) suture
Number of subjects: 200
Study: 6471383

Group type: EXPERIMENTAL
Intervention: CET 30 mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: LMOX 30 mg/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: LMOX 20 mg/kg
Number of subjects: 18
Study: 31855244

Group type: EXPERIMENTAL
Intervention: Platelet function testing guided de-escalation of DAPT
Number of subjects: 2610

Group type: COMPARATOR
Intervention: Control group with prasugrel for 12 months
Number of subjects: 2610

Group type: EXPERIMENTAL
Intervention: Monitoring group with guided de-escalation of DAPT
Number of subjects: 2610
Study: 31855207

Group type: EXPERIMENTAL
Intervention: Postoperative compression using an elastic stocking
Number of subjects: 40

Group type: COMPARATOR
Intervention: Elastic bandaging
Number of subjects: 40
Study: 29125592

Group type: EXPERIMENTAL
Intervention: Edaravone (Radicava)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Riluzole (Rilutek, and generics)
Number of subjects: 0
Study: 26303787

Group type: EXPERIMENTAL
Intervention: Higher intensity treadmill training (HI-TM, 80% HRR)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Lower intensity treadmill training (LO-TM, 50% HRR)
Number of subjects: 34
Study: 22903545

Group type: EXPERIMENTAL
Intervention: CpG stimulation of B cells in vitro and in vivo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BTLA ligation with HVEM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blocking BTLA/HVEM interactions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BTLA/HVEM ligation
Number of subjects: 0
Study: 21850488

Group type: EXPERIMENTAL
Intervention: Philani Plus (+) intervention (n=645 MAR) with four antenatal and four postnatal home visits by trained Mentor Mother CHWs.
Number of subjects: 1239

Group type: COMPARATOR
Intervention: Standard-care control condition (n=594 MAR) of neighborhood clinic-based services.
Number of subjects: 1239
Study: 19398163

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief and extended interventions (CBT)
Number of subjects: 0
Study: 16506060

Group type: EXPERIMENTAL
Intervention: Intensive treadmill running at 80% VO2max to volitional exhaustion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate treadmill running at 60% VO2max
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Downhill treadmill running at -10% at 80% VO2max
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between intensive and eccentric protocols
Number of subjects: 0
Study: 14746625

Group type: EXPERIMENTAL
Intervention: Griseofulvin 500 mg twice daily for 4 weeks
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg daily for 4 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Fluconazole 200 mg once weekly for 4 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Itraconazole 200 mg twice daily for 1 week
Number of subjects: 59
Study: 11758945

Group type: EXPERIMENTAL
Intervention: I-123 MIBG pulmonary accumulation and washout
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normal volunteers (NL)
Number of subjects: 19
Study: 8986530

Group type: EXPERIMENTAL
Intervention: WHO classification of 1975
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: WHO classification of 1994
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: WHO classification of 1975 (reduced to two categories)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: WHO classification of 1994 (reduced to two categories)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: WHO classification of 1975 (intraobserver)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: WHO classification of 1994 (intraobserver)
Number of subjects: 128
Study: 8487051

Group type: EXPERIMENTAL
Intervention: Concomitant fluorouracil (FUra) infusional therapy (1.2 g/m2 per 24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study: 3525302

Group type: EXPERIMENTAL
Intervention: Preventive intervention including diet, cholesterol drugs, anti-hypertensive drugs, anti-smoking advice, and increased physical activity for 6 years
Number of subjects: 6027

Group type: EXPERIMENTAL
Intervention: Treated group
Number of subjects: 6027

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6027
Study: 30843995

Group type: EXPERIMENTAL
Intervention: Auricular Protection
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non‐Protection
Number of subjects: 80
Study: 28130176

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: N/A (comparison between groups)
Number of subjects: 22
Study: 25464425

Group type: EXPERIMENTAL
Intervention: Exercise training program (10 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Regular sports or exercise participation at baseline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sports participation
Number of subjects: 40
Study: 22469637

Group type: EXPERIMENTAL
Intervention: Multimodal (MM) assessment
Number of subjects: 182

Group type: COMPARATOR
Intervention: Routine multidisciplinary assessment (Control)
Number of subjects: 182
Study: 21156659

Group type: EXPERIMENTAL
Intervention: Invasive strategy (angiography with intent to revascularization)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Conservative management strategy
Number of subjects: 138
Study: 19023649

Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose followed by daily 75 mg maintenance dose for 28 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg loading dose followed by daily 10 mg maintenance dose for 28 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 0
Study: 17067774

Group type: EXPERIMENTAL
Intervention: Scoring method treating late responses as incorrect
Number of subjects: 96

Group type: COMPARATOR
Intervention: Scoring method treating late responses as correct
Number of subjects: 96
Study: 12957561

Group type: EXPERIMENTAL
Intervention: Obese subjects
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 50